Watson, Felicia N.
Reynolds, Rebekah A.
Kalata, Anya C.
Shears, Melanie J.
Murphy, Sean C.
Funding for this research was provided by:
National Institutes of Health (U01AI155313)
Article History
Received: 25 February 2026
Accepted: 13 May 2026
First Online: 26 May 2026
Declarations
Ethics approval and consent to participate: All mice were used under an approved IACUC protocol (4317–01 to SCM) and in accordance with relevant guidelines and regulations.
Consent for publication: Not applicable.
Competing interests: S. C. M. filed a patent application on selected aspects of the prime-and-trap concept through the University of Washington. S. C. M. has equity in a startup company (Sound Vaccines, Inc.) that is negotiating with the University of Washington for rights to this intellectual property. The relationship between the authors and Sound Vaccines, Inc., has been reviewed by the University of Washington and complies with all University and State of Washington policies on such activities. The other authors have no financial conflicts of interest.